Author： Kalachand Roshni
Publisher： Adis International
ISSN： 0012-6667
Source： Drugs, Vol.71, Iss.8, 2011-05, pp. : 947-967
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Disease Modifying Agents for Huntington's Disease: What is on the Horizon?
CNS Drugs, Vol. 12, Iss. 5, 1999-11 ,pp. :
Access to resources
Recommend
Disease Modifying Treatments for Multiple Sclerosis: What is on the Horizon?
CNS Drugs, Vol. 11, Iss. 2, 1999-02 ,pp. :
Treatment of Parkinsons Disease: Whats on the Horizon?
By Wu Stacy S.
CNS Drugs, Vol. 19, Iss. 9, 2005-01 ,pp. :
Carboplatin: first-line therapy for ovarian cancer?
Inpharma, Vol. 1, Iss. 1352, 2002-01 ,pp. :
Role of TgDCC-E1A gene therapy in advanced ovarian cancer?
Inpharma, Vol. 1, Iss. 1442, 2004-01 ,pp. :